Kingdon Capital Management, L.L.C. Clovis Oncology, Inc. Call Options Transaction History

Kingdon Capital Management, L.L.C.

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2019 May 14, 2019	SELL	$17.66 - $30.28 $883,000 - $1.51 Million	-50,000 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$11.63 - $32.67 $1.76 Million - $4.93 Million	-151,000 Reduced 75.12%	50,000 $898,000
Q3 2018 Nov 14, 2018	BUY	$29.37 - $49.48 $4.14 Million - $6.98 Million	141,000 Added 235.0%	201,000 $5.9 Million
Q3 2017 Nov 14, 2017	BUY	$67.17 - $84.81 $4.03 Million - $5.09 Million	60,000	60,000 $4.94 Million

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of Kingdon Capital Management, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Kingdon Capital Management, L.L.C. with notifications on news.